Vascular Biogenics Ltd. (VBLT) Financials

NASDAQ Currency in USD Disclaimer

$0.16

north_east NA Past Year
Day's range
$0.15
Day's range
$0.19
$20M$20M$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning201620162017201720182018201920192020202020212021202220220%0%-1000%-1000%-2000%-2000%-3000%-3000%-4000%-4000%-5000%-5000%-6000%-6000%Profit Margin
Profit Margin
Revenue
Earnings

VBLT Income statement / Annual

Last year (2022), Vascular Biogenics Ltd.'s total revenue was $658,000.00, a decrease of 14.32% from the previous year. In 2022, Vascular Biogenics Ltd.'s net income was -$32.22 M. See Vascular Biogenics Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $658,000.00 $768,000.00 $922,000.00 $562,000.00 $585,000.00 $13.86 M $0.00 $0.00 $0.00 $0.00
Cost of Revenue $104,000.00 $365,000.00 $394,000.00 $163,000.00 $235,000.00 $340,000.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $554,000.00 $403,000.00 $528,000.00 $399,000.00 $350,000.00 $13.52 M $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.84 0.52 0.57 0.71 0.6 0.98 0 0 0 0
Research and Development Expenses $21.65 M $22.70 M $19.66 M $15.47 M $15.94 M $17.77 M $12.45 M $11.20 M $10.97 M $13.51 M
General & Administrative Expenses $11.75 M $7.70 M $5.36 M $4.83 M $5.15 M $5.80 M $3.79 M $3.64 M $3.77 M $2.41 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $397,000.00 $562,000.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $11.75 M $7.70 M $5.36 M $4.83 M $5.55 M $6.36 M $3.79 M $3.64 M $3.77 M $2.41 M
Other Expenses $0.00 $0.00 $0.00 $115,000.00 $70,000.00 $0.00 $42,000.00 $34,000.00 $33,000.00 $43,000.00
Operating Expenses $33.41 M $30.40 M $25.01 M $20.41 M $21.56 M $24.18 M $16.28 M $14.87 M $14.78 M $15.96 M
Cost And Expenses $33.51 M $30.76 M $25.41 M $20.58 M $21.79 M $24.52 M $16.28 M $14.87 M $14.78 M $15.96 M
Interest Income $634,000.00 $120,000.00 $363,000.00 $870,000.00 $908,000.00 $335,000.00 $263,000.00 $100,000.00 $15,000.00 $27,000.00
Interest Expense $85,000.00 $44,000.00 $105,000.00 $313,000.00 $0.00 $0.00 $0.00 $117,000.00 $0.00 $0.00
Depreciation & Amortization $1.69 M $120,000.00 $1.56 M $2.58 M $1.16 M $156,000.00 $130,000.00 $122,000.00 $135,000.00 $169,000.00
EBITDA -$31.16 M -$29.88 M -$22.93 M -$17.43 M -$19.93 M -$10.71 M -$16.17 M -$14.65 M -$14.35 M -$16.00 M
EBITDA Ratio -47.36 -38.9 -24.87 -31.01 -34.07 -0.77 0 0 0 0
Operating Income Ratio -49.93 -39.06 -26.55 -35.61 -36.25 -0.77 0 0 0 0
Total Other Income/Expenses Net $549,000.00 $76,000.00 $258,000.00 $557,000.00 $749,000.00 $517,000.00 $273,000.00 -$17,000.00 -$2.63 M -$1.41 M
Income Before Tax -$32.30 M -$29.92 M -$24.23 M -$19.46 M -$20.46 M -$10.14 M -$16.00 M -$14.89 M -$17.41 M -$17.37 M
Income Before Tax Ratio -49.09 -38.96 -26.27 -34.62 -34.97 -0.73 0 0 0 0
Income Tax Expense -$85,000.00 -$1.21 M $105,000.00 $313,000.00 -$749,000.00 -$517,000.00 -$273,000.00 $17,000.00 $2.63 M $1.41 M
Net Income -$32.22 M -$28.71 M -$24.33 M -$19.77 M -$20.46 M -$10.14 M -$16.00 M -$14.89 M -$17.41 M -$17.37 M
Net Income Ratio -48.97 -37.38 -26.39 -35.18 -34.97 -0.73 0 0 0 0
EPS -0.42 -0.41 -0.56 -0.55 -0.62 -0.37 -0.64 -0.73 -3.09 -1.44
EPS Diluted -0.42 -0.41 -0.56 -0.55 -0.62 -0.37 -0.64 -0.73 -3.09 -1.44
Weighted Average Shares Out $77.55 M $69.33 M $43.67 M $35.88 M $32.97 M $27.40 M $24.97 M $20.31 M $5.63 M $12.05 M
Weighted Average Shares Out Diluted $77.55 M $69.33 M $43.67 M $35.88 M $32.97 M $27.40 M $24.97 M $20.31 M $5.63 M $12.05 M
Link